HomeREKA • TLV
add
Rekah Pharmaceutical Industry Ltd
Previous close
ILA 1,349.00
Day range
ILA 1,349.00 - ILA 1,349.00
Year range
ILA 1,130.00 - ILA 1,601.00
Market cap
155.46M ILS
Avg Volume
2.46K
P/E ratio
51.19
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 76.15M | -15.08% |
Operating expense | 19.66M | -2.53% |
Net income | -2.41M | -300.83% |
Net profit margin | -3.16 | -335.82% |
Earnings per share | — | — |
EBITDA | 8.04M | -25.76% |
Effective tax rate | -64.39% | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.80M | -29.59% |
Total assets | 436.57M | -9.60% |
Total liabilities | 276.96M | -15.07% |
Total equity | 159.62M | — |
Shares outstanding | 11.48M | — |
Price to book | 0.97 | — |
Return on assets | 0.01% | — |
Return on capital | 0.02% | — |
Cash Flow
Net change in cash
(ILS) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.41M | -300.83% |
Cash from operations | 8.15M | 22.91% |
Cash from investing | -1.16M | 60.38% |
Cash from financing | -6.26M | 47.80% |
Net change in cash | 733.00K | 108.86% |
Free cash flow | 7.54M | 154.46% |
About
Founded
1947
Website
Employees
421